黑龙江
审稿专家：卜乐
同济大学附属上海市第十人民医院内分泌科主任医师
参考文献
1.Caterinaconte P , Phd K D H , Samuelklein M .Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?[J].JAMA, 2024, 332(1):2.DOI:10.1001/jama.2024.6586.
2.Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl. 4):16-27. doi:10.1111/dom.15728
3.中国营养学会肥胖防控分会专家组,张建端,苟波,等.中国居民健康体重管理之减重行动20条:基于科学循证的专家共识[J].中国糖尿病杂志, 2023, 31(12):881-888.DOI:10.3969/j.issn.1006-6187.2023.12.001.
4.2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025 Aug 19;86(7):536-555. doi: 10.1016/j.jacc.2025.05.024. Epub 2025 Jun 20. PMID: 40539956.
5.中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版)[J]. 中华内分泌代谢杂志,2024,40(07)：545-564.
6.Ji L, Gao L, et al. Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2025 Sep;13(9):777-789.
7.国家卫生健康委食品安全标准与监测评估司,中国疾病预防控制中心营养与健康所,成人肥胖食养指南编写专家组,等.成人肥胖食养指南(2024年版)[J].卫生研究, 2024, 53(3):347-351.
8.Khan MS, Dawood MH, Handelsman Y, Anker SD, Stewart Coats AJ, Green JB, Butler J. Fat, muscle, and anti-obesity medications in cardiovascular disease prevention. Eur Heart J. 2026 Mar 31:ehag201. doi: 10.1093/eurheartj/ehag201. Epub ahead of print. PMID: 41914150.
9.中华医学会内分泌学分会,中国内分泌代谢病专科联盟.中国成人体重管理指南[J].中华内分泌代谢杂志,2025,41(11):891-907
*腾讯医典内容团队出品
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
